We are 4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride CAS:437651-44-0 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name:4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride
Benzoic acid, 4-[3-(dibutylamino)propoxy]-, hydrochloride (1:1)
Molecular Formula: C18H30ClNO3
Physical and Chemical Properties:
Boiling point: 440.7ºC at 760 mmHg
Melting point: 155-157°C
Appearance:Off-white to light yellow powder
Loss on drying:≤0.5%
25kg cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Dronedarone CAS:141626-36-0
Intermediates of Dronedarone hydrochloride CAS:141625-93-6
Related News: Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.530-62-1 It is delivered to hospitals and pharmacies until it reaches the patient.1-[2-(trifluoromethoxy)phenyl]ethanone CAS:220227-93-0 It is delivered to hospitals and pharmacies until it reaches the patient.methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate CAS:258273-50-6 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.